Hepatic Encephalopathy
Conditions
Brief summary
This study is being done to assess the safety and efficacy of using mobile application-based Bristol stool scale to titrate lactulose in prevention episodes of hepatic encephalopathy.
Interventions
OTHERDieta mobile application
Mobile application that functions on mobile phones and allows for tracking of symptoms, dietary intake, and stool characteristics using logs and pictures. Users of the application track symptoms by completing questionnaires regarding stool frequency, consistency, and mental status changes. Users can track dietary intake and stool characteristics by taking time-stamped photos of all dietary intake and bowel movements.
Sponsors
Mayo Clinic
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Ability to provide written, informed consent. * Currently taking lactulose daily for prevention of hepatic encephalopathy.
Exclusion criteria
* Recent change in dosing of opioid medication. * Previous Colorectal Surgery. * Active diarrheal illness. * Lack of smartphone or other smart device at home.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Achievement of daily stool goal | 4 weeks | Number of subject to achieve daily stool goal, determined if use of the mobile application leads to improved rates of meeting daily stool goal (3-4 stools per day of Bristol Stool Scale 3-4) |
Countries
United States
Outcome results
None listed